News articles about Biostar Pharmaceuticals (NASDAQ:BSPM) have been trending positive on Sunday, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Biostar Pharmaceuticals earned a coverage optimism score of 0.45 on Accern’s scale. Accern also assigned headlines about the company an impact score of 44.3246008902332 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Shares of Biostar Pharmaceuticals (NASDAQ:BSPM) traded up 4.83% during mid-day trading on Friday, reaching $1.52. The company’s stock had a trading volume of 56,522 shares. Biostar Pharmaceuticals has a 52-week low of $1.18 and a 52-week high of $7.06. The firm’s 50 day moving average is $1.37 and its 200-day moving average is $1.60. The company’s market capitalization is $4.05 million.
TRADEMARK VIOLATION WARNING: This piece was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://ledgergazette.com/2017/10/08/positive-press-coverage-somewhat-unlikely-to-affect-biostar-pharmaceuticals-bspm-share-price.html.
About Biostar Pharmaceuticals
Biostar Pharmaceuticals, Inc (Biostar) is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co, Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, manufactures and markets pharmaceutical products for various diseases and conditions in the People’s Republic of China (PRC or China).
Receive News & Ratings for Biostar Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biostar Pharmaceuticals Inc. and related companies with MarketBeat.com's FREE daily email newsletter.